Government Proposes Separate Licence for Wholesale Sale of Bulk Drugs Under Drugs Rules, 1945

The way bulk drugs are sold in wholesale markets could change if a new proposal from the Union Health Ministry gets the green light. The ministry wants wholesalers dealing in bulk drugs to obtain a separate licence, instead of covering these sales under the common licence currently used for both bulk drugs and formulations.
The proposal has been issued as a draft amendment to the Drugs Rules, 1945, through notification G.S.R. No. 987(E), dated November 2, 2026.
What Is Changing for Wholesalers?
Under the existing system, one licence covers the wholesale sale of formulations as well as bulk drugs. The proposed amendment would separate the two.
Wholesalers handling active and inactive bulk substances would need to apply for a dedicated licence. The rules would also cover drugs falling under the Narcotic Drugs and Psychotropic Substances (NDPS) Act, 1985.
Another requirement is that bulk drug sales must take place under the supervision of a competent person. This is intended to make businesses more accountable for the way these substances are handled and distributed.
Why Does the Ministry Want Separate Licensing?
Bulk drugs are used in the manufacture of medicines, and the ministry wants closer oversight of their movement through wholesale channels.
The proposed system is intended to improve monitoring of bulk drug sales, strengthen enforcement concerning antimicrobial resistance and help keep track of the movement of NDPS drugs.
The proposal has already been considered by the Drugs Consultative Committee and the Drugs Technical Advisory Board.
When Could the New Rules Apply?
The changes are still at the draft stage. The ministry has invited objections and suggestions from stakeholders and members of the public within 30 days of the draft rules being made available.
Existing licence holders will also get time to adjust. The new requirements will apply after their current retention period ends or 12 months after the final publication of the amendment, whichever comes later.
Read More: NLC India Share Price Surges as NLC India Renewables Files IPO Papers!
Conclusion
If approved, the amendment will mean an additional licensing requirement for wholesalers dealing in bulk drugs. For now, businesses have an opportunity to review the proposal and submit their feedback before the government finalises the rules.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.
Published on: Nov 19, 2026, 3:15 PM IST

Team Angel One
- Government Revises Export Promotion Scheme to Increase Support for Indian Exporters
- Maharashtra Wage Rules 2026 Cap Weekly Working Hours at 48; Set New Overtime and Wage Deduction Rules
- India Imposes 162.5% Duty on Bulk Scotch Imports Despite UK Trade Pact
- HAL, BEL and Other Defence Stocks in Focus as Defence Ministry Seeks 20% Capex Hike for FY27
- Defence Ministry Signs ₹1,976 Crore Contract with Israel for Barak Missile Upgrade




